BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12113055)

  • 1. AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):323-9. PubMed ID: 12113055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Magic bullets"--monoclonal antibodies in acute leukemia and non-Hodgkin's lymphoma treatment].
    Łuczyński W; Krawczuk-Rybak M
    Postepy Hig Med Dosw; 2002; 56(6):789-801. PubMed ID: 12669700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody therapy of leukaemias and lymphomas.
    Jacobs SA; Foon KA
    Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
    Fanale MA; Younes A
    Drugs; 2007; 67(3):333-50. PubMed ID: 17335294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies in hematology in 2009].
    Bonnet C; Beguin Y; De Prijck B; Witvrouw N; Hustinx R; Fillet G
    Rev Med Liege; 2009; 64(5-6):268-73. PubMed ID: 19642457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody therapy of lymphoma.
    Illidge TM; Bayne MC
    Expert Opin Pharmacother; 2001 Jun; 2(6):953-61. PubMed ID: 11585011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
    Rao AV; Schmader K
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
    Liu C; DeNardo G; Tobin E; DeNardo S
    Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rituximab (antiCD20 monoclonal antibody) and molecular-biological negativity in the treatment of patients with follicular lymphoma--a way to a cure?--Editorial].
    Trnený M
    Vnitr Lek; 2007 Oct; 53(10):1029-30. PubMed ID: 18072423
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel humanized anti-CD20 antibody with potent anti-tumor activity against non-Hodgkin's lymphoma.
    Zhang H; Song L; Ye H; Hu L; Liang W; Liu D
    Cell Physiol Biochem; 2013; 32(3):645-54. PubMed ID: 24022075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
    Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
    Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteins in haematology].
    Clarenbach RE; Mey U
    Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ten years since the successful introduction of the first monoclonal antibody (rituximab) into the therapy of lymphomas].
    Trnený M; Klener P
    Cas Lek Cesk; 2007; 146(7):578-85. PubMed ID: 17722844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of monoclonal antibody therapy for malignant lymphoma].
    Ogura M
    Nihon Rinsho; 2002 Mar; 60(3):505-16. PubMed ID: 11904966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab immunotherapy for non-Hodgkin's lymphoma.
    White CA
    Cancer Biother Radiopharm; 1999 Aug; 14(4):241-50. PubMed ID: 10850310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal selection of CD20-negative non-Hodgkin's lymphoma cells after treatment with anti-CD20 antibody rituximab.
    Schmitz K; Brugger W; Weiss B; Kaiserling E; Kanz L
    Br J Haematol; 1999 Aug; 106(2):571-2. PubMed ID: 10460626
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-based therapy of non-Hodgkin's lymphoma.
    Foran JM
    Best Pract Res Clin Haematol; 2002 Sep; 15(3):449-65. PubMed ID: 12468399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma.
    King KM; Younes A
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):177-86. PubMed ID: 12113023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.